Active surveillance in intermediate risk prostate cancer: is it safe?

by Henk G. van der Poel, Roderick C.N. van den Bergh
Published 2016-06-01

First Report of Two Cases of Acute Gastric Ischemia after Robot-Assisted Radical Cystectomy

by Nikolaos Grivas, Alexander D. Horsch, Esther Wit, Annemarie Bruining, Johanna van Sandick, Henk G. van der Poel
Published 2021-01-01

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

by Maxim Rybalov, Hildo J. K. Ananias, Hilde D. Hoving, Henk G. van der Poel, Stefano Rosati, Igle J. de Jong
Published 2014-04-01

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

by Laura Stokkel, Henk G van der Poel, Sigrun I Langbein, J Martijn Kerst, Jeroen de Jong, Bas W. G van Rhijn
Published 2020-01-01

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer

by Ekaterina Nevedomskaya, Suzan Stelloo, Henk G. van der Poel, Jeroen de Jong, Lodewyk F.A. Wessels, Andries M. Bergman, Wilbert Zwart
Published 2016-03-01

Five Years of the CC-ERUS Fellowship: A Survey of the Experiences and Post-fellowship Work of the Fellows

by Alexander J.W. Beulens, Paulo Dell’Oglio, Hannah Kiss, Willem M. Brinkman, Alessandro Larcher, Alexandre Mottrie, Christian Wagner, Henk G. van der Poel
Published 2020-07-01

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

by Maarten L. Donswijk, Pim J. van Leeuwen, Erik Vegt, Zing Cheung, Stijn W. T. P. J. Heijmink, Henk G. van der Poel, Marcel P. M. Stokkel
Published 2020-08-01

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer

by Charlotte L. Deijen, Gerbert L. Vrijenhoek, Eva E. Schaake, Wouter V. Vogel, Luc M.F. Moonen, Floris J. Pos, Henk G. van der Poel, Gerben R. Borst
Published 2021-09-01

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer

by Rosanne CV. Van der Roest, Petra J. van Houdt, Stijn WTPJ. Heijmink, Jeroen de Jong, André M. Bergman, Wilbert Zwart, Uulke A. van der Heide, Henk G. van der Poel
Published 2016-07-01

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage...

by Henk B. Luiting, Sebastiaan Remmers, Dennie Meijer, André N. Vis, Maarten Donswijk, Daniela E. Oprea-Lager, Louise Emmett, Isabel Rauscher, Henk G. Van der Poel, Monique J. Roobol, Pim J. van Leeuwen
Published 2021-06-01

A Prospective, Observational, Multicentre Study Concerning Nontechnical Skills in Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy

by Alexander J.W. Beulens, Willem M. Brinkman, Evert L. Koldewijn, Ad J.M. Hendrikx, Jean Paul A. van Basten, Jeroen J.G. van Merriënboer, Henk G. Van der Poel, Chris H. Bangma, Cordula Wagner
Published 2020-07-01

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

by Catarina Dinis Fernandes, Cuong V. Dinh, Iris Walraven, Stijn W. Heijmink, Milena Smolic, Joost J.M. van Griethuysen, Rita Simões, Are Losnegård, Henk G. van der Poel, Floris J. Pos, Uulke A. van der Heide
Published 2018-07-01

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based...

by Barbara M. Wollersheim, Kristel M. van Asselt, Henk G. van der Poel, Henk C. P. M. van Weert, Michael Hauptmann, Valesca P. Retèl, Neil K. Aaronson, Lonneke V. van de Poll-Franse, Annelies H. Boekhout
Published 2020-07-01

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors

by Teele Kuusk, Maarten L. Donswijk, Renato A. Valdés Olmos, Roderick E. De Bruijn, Oscar R. Brouwer, Kees Hendricksen, Simon Horenblas, Katarzyna Jóźwiak, Warner Prevoo, Henk G. Van Der Poel, Bas W. G. Van Rhijn, Esther M. Wit, Axel Bex
Published 2018-12-01

A DROP-IN beta probe for robot-assisted 68Ga-PSMA radioguided surgery: first ex vivo technology evaluation using prostate cancer specimens

by Francesco Collamati, Matthias N. van Oosterom, Micol De Simoni, Riccardo Faccini, Marta Fischetti, Carlo Mancini Terracciano, Riccardo Mirabelli, Roberto Moretti, Judith olde Heuvel, Elena Solfaroli Camillocci, Florian van Beurden, Henk G. van der Poel, Renato A. Valdes Olmos, Pim J. van Leeuwen, Fijs W. B. van Leeuwen, Silvio Morganti
Published 2020-08-01

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

by Bianca Cioni, Anniek Zaalberg, Judy R. van Beijnum, Monique H. M. Melis, Johan van Burgsteden, Mauro J. Muraro, Erik Hooijberg, Dennis Peters, Ingrid Hofland, Yoni Lubeck, Jeroen de Jong, Joyce Sanders, Judith Vivié, Henk G. van der Poel, Jan Paul de Boer, Arjan W. Griffioen, Wilbert Zwart, Andries M. Bergman
Published 2020-09-01

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

by Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Published 2020-09-01